Innovative Intermittent Preventive Treatment Approaches to Reduce Malaria Burden in School-age Children in Burkina Faso

NCT05946642 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

13000

Enrollment

OTHER

Sponsor class

Conditions

Malaria

Interventions

DRUG: Sulphadoxine-Pyrimethamine/Amodiaquine
DRUG: Dihydroartemisinin/Piperaquine (DP) plus Ivermectin (IVM)

Sponsor

Malaria Consortium